Mr. Michael Perron reports

MTL CANNABIS ANNOUNCES SHAREHOLDER APPROVAL OF ARRANGEMENT WITH CANOPY GROWTH

At MTL Cannabis Corp.'s special meeting of shareholders held on Feb. 17, 2026, MTL shareholders approved the special resolution authorizing the previously announced plan of arrangement under the Canada Business Corporations Act, pursuant to which, among other things, Canopy Growth Corp. will acquire all of the issued and outstanding common shares of MTL Cannabis in accordance with the terms of the arrangement agreement dated Dec. 14, 2025, as amended on Jan. 6, 2026, between MTL Cannabis and Canopy Growth, all as more particularly described in the management information circular of MTL Cannabis dated Jan. 15, 2026.

The arrangement resolution required approval by (a) at least two-thirds of the votes cast by MTL shareholders present in person or represented by proxy and entitled to vote at the meeting; and (b) a majority of the votes cast by MTL shareholders present in person or represented by proxy and entitled to vote at the meeting, excluding for this purpose votes attached to MTL shares required to be excluded pursuant to Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions. Details on the voting results at the meeting are shown in the attached table.

MTL Cannabis intends to seek a final order of the Supreme Court of British Columbia to approve the arrangement at a hearing expected to be held on Feb. 23, 2026. Assuming timely receipt of all necessary court, third party approvals and the satisfaction of all other conditions, closing of the arrangement is expected to occur before the end of March, 2026.

Further information about the arrangement is available in the circular and related proxy materials, which are available on SEDAR+ under MTL Cannabis's issuer profile.

About MTL Cannabis Corp.

MTL Cannabis is the parent company of Montreal Medical Cannabis Inc., a licensed producer operating from a 57,000-square-foot licensed indoor grow facility in Pointe Claire, Que.; Abba Medix, a licensed producer in Pickering, Ont., that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Que., growing best-in-class indoor cannabis, in its 64,000-square-foot production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.

As a flower-first company built for the modern street, Montreal Medical Cannabis Inc. uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. Montreal Medical Cannabis Inc. focuses on craft quality cannabis products, including lines of dried flower, prerolls and hash marketed under the MTL Cannabis, Low Key by MTL and R'belle brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. Montreal Medical Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis.

It is MTL Cannabis's goal for Abba Medix to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services.

We seek Safe Harbor.